Kolexia
Doz Francois Pédiatrie
Doz Francois
Pédiatrie
Clcc Institut Curie
Paris, France
313 Activités
257 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Médulloblastome Rétinoblastome Tumeurs du cerveau Gliome Tumeurs de la rétine Tumeurs du cervelet Tumeurs du système nerveux central Tumeurs du système nerveux Prédisposition génétique à une maladie

Collaborateurs

Voir plus
Aerts Isabelle
Aerts Isabelle
Clcc Institut Curie, Paris, France
Bourdeaut Franck
Bourdeaut Franck
Clcc Institut Curie, Paris, France
Geoerger Birgit
Geoerger Birgit
Gustave-Roussy, Villejuif, France
Dufour Christelle
Dufour Christelle
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Bayer
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors: Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Essai Clinique (Emd Serono)   08 mars 2024
NAVIGATE: A Study to Learn How Well the Drug Larotrectinib Works in Adults With Different Solid Cancers With a Change in the Genes Called NTRK Fusion
Essai Clinique (Bayer)   19 février 2024
SCOUT: A Phase 1/2 Study of the Oral TRK Inhibitor Larotrectinib in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors
Essai Clinique (Bayer)   19 février 2024
SIOP-PNET-4: A Prospective Randomised Controlled Trial of Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma
Essai Clinique (Institut Curie)   29 janvier 2024
LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping.
Journal of neuropathology and experimental neurology   17 janvier 2024
Genotype-phenotype correlations in retinoblastoma
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo.
Cancer reports (Hoboken, N.J.)   26 décembre 2023
EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
CTNI-75. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer: A Phase 1 Study of the Oral TRK Inhibitor Larotrectinib in Adult Patients With Solid Tumors
Essai Clinique (Bayer)   02 novembre 2023